Partner Content Partner Content BioPharmaLogic, Antikor Biopharma and UCL Host 2 Must Attend... ADC Summit
Partner Content Partner Content Exclusive Interview Released with HPAPI Project Services SMi's 2nd Annual HPAPI 2018 Conference
Partner Content Partner Content BioPharmaLogic, Antikor Biopharma and UCL Host Two Workshops... SMi's 6th annual ADC Conference
Partner Content Partner Content Exclusive Speaker Interview from Seattle Genetics for SMi’s ... Interview from Seattle Genetics
Partner Content Partner Content Hear the Keynote Addresses from MedImmune and Spirogen this ... Antibodies & Antibody Drug Conjugates
Partner Content Partner Content Hear from Janssen and Antikor Biopharma at SMi’s ADC Confere... Janssen and Antikor Biopharma Speak this April
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
